International Clinical Research Centre St Anne's University Hospital Brno Czech Republic

Memory Clinic Department of Neurology 2nd Faculty of Medicine Charles University and Motol University Hospital Prague Czech Republic

Zobrazit více v PubMed

Angelucci F, Čechová K, Průša R, Hort J. Amyloid beta soluble forms and plasminogen activation system in Alzheimer’s disease: consequences on extracellular maturation of brain-derived neurotrophic factor and therapeutic implications. CNS Neurosci Ther. 2018;25:303–313. PubMed PMC

Angelucci F, Veverova K, Katonová A, Vyhnalek M, Hort J. Plasminogen activator inhibitor-1 serum levels in frontotemporal lobar degeneration. J Cell Mol Med. 2024;28:e18013. PubMed PMC

Denorme F, Wyseure T, Peeters M, Vandeputte N, Gils A, Deckmyn H, Vanhoorelbeke K, Declerck PJ, De Meyer SF. Inhibition of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 reduces ischemic brain damage in mice. Stroke. 2016;47:2419–2422. PubMed

Dimova EY, Samoylenko A, Kietzmann T. Oxidative stress and hypoxia: implications for plasminogen activator inhibitor-1 expression. Antioxid Redox Signal. 2004;6:777–791. PubMed

Gerenu G, Martisova E, Ferrero H, Carracedo M, Rantamäki T, Ramirez MJ, Gil-Bea FJ. Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer’s neuropathology and cognitive deficits. Biochim Biophys Acta Mol Basis Dis. 2017;1863:991–1001. PubMed

Guo C, Wang T, Zhang D, Ge X, Li J. Plasminogen decreases Aβ42 and Tau deposition, and shows multi-beneficial effects on Alzheimer’s disease in mice and humans. Biochem Biophys Res Commun. 2023;654:102–111. PubMed

Jiang CS, Rana T, Jin LW, Farr SA, Morley JE, Qin H, Liu G, Liu RM. Aging, plasminogen activator inhibitor 1, brain cell senescence, and Alzheimer’s disease. Aging Dis. 2023;14:515–528. PubMed PMC

Lebas H, Guérit S, Picot A, Boulay AC, Fournier A, Vivien D, Cohen Salmon M, Docagne F, Bardou I. PAI-1 production by reactive astrocytes drives tissue dysfibrinolysis in multiple sclerosis models. Cell Mol Life Sci. 2022;79:323. PubMed PMC

Medcalf RL. Fibrinolysis: from blood to the brain. J Thromb Haemost. 2017;15:2089–2098. PubMed

Reuland CJ, Church FC. Synergy between plasminogen activator inhibitor-1, α-synuclein, and neuroinflammation in Parkinson’s disease. Med Hypotheses. 2020;138:109602. PubMed

Rouch A, Vanucci-Bacqué C, Bedos-Belval F, Baltas M. Small molecules inhibitors of plasminogen activator inhibitor-1 - an overview. Eur J Med Chem. 2015;92:619–636. PubMed

Stevenson TK, Moore SJ, Murphy GG, Lawrence DA. Tissue plasminogen activator in central nervous system physiology and pathology: from synaptic plasticity to Alzheimer’s disease. Semin Thromb Hemost. 2022;48:288–300. PubMed PMC